Fiduciary Alliance’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-42
Closed -$1.03K 873
2023
Q2
$1.03K Buy
+42
New +$1.35K ﹤0.01% 858
2023
Q1
Sell
-542
Closed -$24.4K 804
2022
Q4
$24.4K Buy
+542
New +$24.5K 0.01% 293

Other funds holding TNDM

Fiduciary Alliance's TNDM Position: Q3 2023 in Review

Fiduciary Alliance sold out of Tandem Diabetes Care (TNDM) in Q3 2023, closing a stake of 42 shares — an estimated $1.03K sold.

Fiduciary Alliance first reported a position in TNDM in Q4 2022 and held it in 2 quarters. The position peaked at $24.4K in Q4 2022. 226 funds tracked by Wall St. Rank hold TNDM as of Q3 2023.

  • Fiduciary Alliance reported no remaining Tandem Diabetes Care position as of Q3 2023 after selling out during the quarter.
  • Fiduciary Alliance sold 42 Tandem Diabetes Care shares in Q3 2023, an estimated $1.03K.
  • Fiduciary Alliance first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 2 quarters.
  • Fiduciary Alliance's Tandem Diabetes Care position peaked at $24.4K in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2023.

Based on Fiduciary Alliance's 13F filing for Q3 2023, filed 18 Oct 2023.